Surgical Approach for the Treatment of Hirschsprung Disease Using the Swenson Technique (SMILES) (SMILES)

March 9, 2026 updated by: University Hospital, Angers

A Bicenter Retrospective Comparative Study of the Surgical Approach for the Treatment of Hirschsprung Disease Using the Swenson Technique

Hirschsprung disease (HD) is a rare congenital disorder of the enteric nervous system, affecting approximately 1 in 5,000 live births. It is characterized by the absence of ganglion cells in the distal colon, leading to functional intestinal obstruction due to impaired peristalsis. Surgical treatment consists of resection of the aganglionic segment-most commonly rectosigmoid-followed by a colo-rectal, colo-anal, or ileo-anal anastomosis.

Among colo-anal pull-through procedures, the Swenson technique was historically performed through an exclusively transanal approach, which carries a risk of sphincter injury correlated with operative duration. More recently, combined laparoscopic and transanal approaches have been developed to reduce this risk, although they may be associated with higher overall complication and reoperation rates.

The Swenson procedure can be performed using a single-port laparoscopic approach, a technique that is sparsely described in the literature and rarely practiced in France. Single-port laparoscopy represents an emerging surgical technique that, despite increased technical complexity for surgeons, may further enhance postoperative recovery and cosmetic outcomes compared to conventional multiport laparoscopy.

The objective of this study is to describe the outcomes of single-port laparoscopic Swenson pull-through in children with Hirschsprung disease and to compare them with outcomes obtained using more conventional approaches, namely exclusive transanal surgery or combined multiport laparoscopic and transanal approaches.

Study Overview

Study Type

Observational

Enrollment (Estimated)

70

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child

Accepts Healthy Volunteers

No

Sampling Method

Probability Sample

Study Population

Children under 16 years of age with diagnosis of Hirschsprung disease confirmed by initial rectal biopsy and postoperative pathological examination

Description

Inclusion Criteria:

  • Children under 16 years of age
  • Diagnosis of Hirschsprung disease confirmed by initial rectal biopsy and postoperative pathological examination
  • Primary Swenson coloanal pull-through performed at Angers or Caen University Hospital between January 1, 2010 and June 30, 2025

Exclusion criteria

  • Parental or legal guardian opposition to the use of medical data for research purposes
  • Hirschsprung disease treated with other surgical techniques (Duhamel, Soave, De La Torre, TERPT)
  • Patients operated on in another hospital
  • Patients who underwent rectosigmoid resection for causes of constipation other than Hirschsprung disease

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
SIL-Swenson
Swenson coloanal pullthrough with single incision laparoscopy

TA-Swenson consist of total trananal endorectal pullthrough after a short submucosal dissection of the last part of the rectum.

Laparoscopy-assisted Swenson pull-through consists of laparoscopic mobilization of the aganglionic colon with intraoperative level confirmation, followed by a transanal resection of the aganglionic segment and a primary coloanal anastomosis

CL-Swenson
Swenson coloanal pullthrough with conventional (multiport) laparoscopy

TA-Swenson consist of total trananal endorectal pullthrough after a short submucosal dissection of the last part of the rectum.

Laparoscopy-assisted Swenson pull-through consists of laparoscopic mobilization of the aganglionic colon with intraoperative level confirmation, followed by a transanal resection of the aganglionic segment and a primary coloanal anastomosis

TA-Swenson
Swenson coloanal pullthrough with exclusive trananal approach

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
To compare the short-term effectiveness of different surgical laparoscopic approaches used for the Swenson technique.
Time Frame: From surgery to 12 months postoperatively

Short-term effectiveness, defined as spontaneous bowel transit without obstructive-spectrum events during the first postoperative year, including:

  • Constipation
  • Delayed resumption of oral feeding
  • Sphincter hypertonicity
  • Hirschsprung-associated enterocolitis
From surgery to 12 months postoperatively

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
To compare intraoperativensurgical efficiency according to surgical approach
Time Frame: During surgery (day 0)
Surgical efficiency, defined as operative time for coloanal anastomosis completion without conversion, including the approach for intraoperative frozen-section biopsy.
During surgery (day 0)
To compare immediate postoperative recovery
Time Frame: At hospital discharge (average 5 days)

Recovery, defined as hospital discharge in good health, which includes:

  • Return of bowel function
  • Resumption of oral feeding
  • Absence of early postoperative complications, particularly infectious complications (surgical site infection, intra-abdominal infection, sepsis)
At hospital discharge (average 5 days)
Short-term complications
Time Frame: From hospital discharge to 30 days after surgery
All early postoperative complications graded according to the Clavien-Madadi classification
From hospital discharge to 30 days after surgery
Long-term complications
Time Frame: From 31 days after surgery up to the last clinical follow-up visit (mean follow-up: 5.5 years)
All late postoperative complications graded according to the Clavien-Madadi classification
From 31 days after surgery up to the last clinical follow-up visit (mean follow-up: 5.5 years)
Long-term continence outcomes
Time Frame: Assessed after toilet training age (≥3-4 years old) and up to the last clinical follow-up visit (mean follow-up: 5.5 years)

Assessed using the Krickenbeck score, which includes:

  • Bowel movements perception
  • Soining (graded 0 - absence to 3 - constant/social prolem)
  • Constipation (graded from 0 - absence to 3 - resistant to diet and laxatives)
Assessed after toilet training age (≥3-4 years old) and up to the last clinical follow-up visit (mean follow-up: 5.5 years)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: SCHMITT Françoise, University hospital of Angers

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

March 1, 2026

Primary Completion (Estimated)

June 1, 2026

Study Completion (Estimated)

June 1, 2027

Study Registration Dates

First Submitted

February 11, 2026

First Submitted That Met QC Criteria

March 9, 2026

First Posted (Actual)

March 12, 2026

Study Record Updates

Last Update Posted (Actual)

March 12, 2026

Last Update Submitted That Met QC Criteria

March 9, 2026

Last Verified

February 1, 2026

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Hirschsprung Disease

Clinical Trials on transanal or laparoscopy assisted Swenson coloanal pullthrough

Subscribe